Health
Roche gantenerumab improves biomarkers in inherited form of Alzheimer’s disease – PMLiVE
However, anti-amyloid antibody did not show evidence of cognitive benefit for patients
A new study, published in Nature Medicine, has showed that Roche’s investigational candidate gantenerumab led to improvements in a number of biomarkers in patients with an inherited form of Alzheimer’s disease.
In the DIAN-TU-001 trial, researchers from…
Continue Reading
-
General16 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News23 hours agoBarn-owl project reducing farmers’ reliance on poison to manage rats and mice
-
Noosa News21 hours agoSouth-west Queensland highway closed after truck carrying oxygen cylinders catches fire
-
General23 hours agoThe best ways to clean your home coffee machine